BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Entero Therapeutics, Inc. (Nasdaq - ENTO), Pulmatrix, Inc. (Nasdaq – PULM), Liberty Broadband Corporation (Nasdaq – LBRDA, LBRDK, LBRDP), Manitex International, In…

/EIN News/ -- BALA CYNWYD, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Entero Therapeutics, Inc. (Nasdaq - ENTO)

Under the terms of the Merger Agreement, Entero will merge with Journey Therapeutics, Inc. (“Journey”). Upon completion, shareholders of Journey will acquire 99% of the equity of Entero.The investigation concerns whether the Entero Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/entero-therapeutics-inc-nasdaq-ento/ .

Liberty Broadband Corporation (Nasdaq – LBRDA, LBRDK, LBRDP)

Under the terms of the agreement, Liberty Broadband will be acquired by Charter Communications, Inc. (Nasdaq - CHTR). Under the terms of the deal, each holder of Liberty Broadband common stock will receive 0.236 of a share of Charter common stock per share of Liberty Broadband common stock held. Each holder of Liberty Broadband preferred stock will receive one share of newly issued Charter cumulative redeemable preferred stock per share of Liberty Broadband preferred stock held. The investigation concerns whether the Liberty Broadband Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Charter is paying fair value for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/liberty-broadband-corporation-nasdaq-lbrda-lbrdk-lbrdp/.

Pulmatrix, Inc. (Nasdaq – PULM)

Under the terms of the agreement, Pulmatrix will be acquired by Cullgen Inc. (“Cullgen”). Pre-merger Pulmatrix stockholders are expected to own approximately 3.6% of the combined company, and pre-merger Cullgen stockholders are expected to own approximately 96.4% of the combined company which will operate under the name Cullgen Inc., be headquartered in San Diego, CA and trade on The Nasdaq Capital Market (Nasdaq).The investigation concerns whether the Pulmatrix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Company shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/pulmatrix-inc-nasdaq-pulm/.

Manitex International, Inc. (Nasdaq - MNTX)

Under the terms of the agreement, Manitex will be acquired by Tadano Ltd. (“Tadano”) in an all-cash transaction. Manitex shareholders will receive $5.80 per share in cash in a deal valued at approximately $223 million. The investigation concerns whether the Manitex Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Tadano is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/manitex-international-inc-nasdaq-mntx-2/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.